🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. cocaine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  2. d-amphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  3. d-amphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule completed

    1 trial

  4. d-amphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule active

    1 trial

  5. delta 9 tetrahydrocannabinol

    BRIGHT MINDS BIOSCIENCES INC.

    COMT Gene Polymorphism

    phase 1 small molecule completed

    1 trial

  6. drug condition

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  7. eszopiclone

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    phase 1 small molecule completed

    1 trial

  8. iTBS to the left dlPFC

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 other completed

    1 trial

  9. l-THP (l-tetrahydropalmatine)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use

    phase 1 small molecule completed

    1 trial

  10. lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Renally Impaired Subjects

    phase 1 small molecule completed

    1 trial

  11. mHealth application (custom)

    BRIGHT MINDS BIOSCIENCES INC.

    Cognitive Function Abnormal

    phase 1 other completed

    1 trial

  12. metyrapone & oxazepam

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  13. mitragynine

    BRIGHT MINDS BIOSCIENCES INC.

    Safety and Tolerability in Healthy Subjects

    phase 1 small molecule active

    1 trial

  14. oral naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  15. quitSTART Mobile Application

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Vaping

    phase 1 other active

    1 trial

  16. radioactive substance

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 1 other active

    1 trial

  17. routine HIV testing

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 1 other completed

    1 trial

  18. standard care

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 1 other terminated

    1 trial

  19. veliparib

    BRIGHT MINDS BIOSCIENCES INC.

    Small Cell Lung Cancer SCLC

    phase 1 small molecule active

    1 trial

  20. 400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

    BRIGHT MINDS BIOSCIENCES INC.

    Benign Paroxysmal Positional Vertigo

    approved small molecule completed

    1 trial

  21. 99mTc-Macro Albumin Aggregate

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma

    approved small molecule completed

    1 trial

  22. Adderall

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial

  23. Algorithm Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved small molecule completed

    1 trial

  24. Amantadine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources